Can We Discharge TAVR Patients the Same Day?

For over a decade, TAVR has been showing great benefits, but conduction abnormalities such as RBBB and prior A-V block, continue to be one of the biggest challenges, since in different series the need for definite pacemaker implantation (PPM) varies between 17 to 30% in the large, randomized studies of self-expanding valves.  

alta en el mismo día post TAVI

Even though we are well aware a higher implantation depth of the percutaneous valve (cusp overlapping) has been shown to significantly reduce the need for PPM, it has not yet been tested in large, randomized studies. 

68,482 patients receiving TAVR via femoral approach were looked at. 20,261 (29.6%) of these patients got early discharge (ED), between 0 and 1 day, and 48,221 late discharge (LD), ≥2 days.

Primary end point was rehospitalization for PPM. 

ED patients were younger (79 ± 8 years vs. 80 ± 7.6 years p < 0.01), there were more men, fewer were diabetic or presented kidney failure, COPD, peripheral vascular disease, or stroke, and had more programmed procedures. Besides, they presented fewer conduction abnormalities such as first and second-degree AV block, RBBB and fascicular blocks. 

Read also: Heparin Pretreatment in STEACS Treatment: A New Old Ally?

There were no differences in primary end point between ED and LD patients (2.0% vs. 1.8%; adjusted odds ratio: 1.15; 95% confidence interval: 0.95–1.39; p=0.15). Neither were there differences in readmissions for PPM at 30 and 60 days, or between elective and non-elective readmission. 

Mean time for readmission was 5 days, with no differences between ED and LD.

ED was associated to lower hospital expenses compared against LD.

Read also: RIPCORD 2 Study: Routine Assessment Using Pressure Wires in Acute Coronary Syndrome.

Predictors of PPM were 2-degree A-V block, fascicular blocks, RBBB and kidney failure. 

Conclusion

Early and late discharge TAVR patients who did not require permanent pacemaker implantation during hospitalization showed similar readmission rate for pacemaker implantation. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation. 

Reference: Ahmed M. Elzanaty, et al. Catheter Cardiovasc Interv. 2022;100:245–253.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...